Trade MESO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Mesoblast Limited American Depositary Shares (MESO) is trading at US$14.22, up 0.99% today as of Oct 5, 16:00 EDT. The company has a market capitalisation of US$2.2B. Over the past 52 weeks, MESO has traded between US$13.05 and US$21.50. On Syfe you can trade MESO with $0 commission and add it to your watchlist.
| Previous close | US$14.08 |
|---|---|
| Market cap | US$2.2B |
| 52-week range | US$13.05 – US$21.50 |
| Volume | 179.74K |
| Exchange | US |
Mesoblast Limited American Depositary Shares
Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.
Year: 2009
Mesoblast Fiscal 2026 Loss Narrows, Revenue Rises
Aug 27, 7:56 AM · MT Newswires
Stay on top of MESO
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
